Could a malaria drug help kids with rare lung disease?
NCT ID NCT03822780
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether hydroxychloroquine, a medicine used for malaria and autoimmune conditions, can help children with a rare genetic lung disease that affects the lungs' natural cleaning fluid. 25 children took the drug, and researchers checked if their need for extra oxygen improved over 6 months. The goal was to see if the drug could control the disease and reduce breathing problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT DYSFUNCTION DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.